| Structure |
Chemical Name |
CAS |
MF |
 |
Peramivir Impurity D |
|
|
 |
1-(3-amino-4-(benzyloxy)phenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethan-1-ol |
345288-56-4 |
C25H30N2O3 |
 |
Istradefylline iMpurity |
|
|
 |
Tenofovir Impurity 76 |
|
|
 |
Dapagliflozin Impurity 47 |
|
|
 |
Trelagliptin Impurity 24 |
|
|
 |
Dapagliflozin Impurity 25 |
|
|
 |
Itraconazole iMpurity 6 |
|
|
 |
Cefaclor Impurity 3 |
|
|
 |
Acyclovir Impurity 12 |
|
|
 |
TerButaline Ep Impurity B |
|
|
![1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1365267-36-2.gif) |
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1365267-36-2 |
C36H36N6O10 |
 |
Doxofylline Impurity 20 |
|
|
 |
(E)-4-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3- yl)methyl)(methyl)amino)-4-oxobut-2-enoic acid |
|
C21H18FN3O5S |
 |
Apixaban Impurity 39 |
|
|
 |
Dapoxetine impurity 20 |
|
|
amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
 |
Gefitinib impurity M |
|
|
 |
(S)-Indacaterol |
1384188-70-8 |
C24H29ClN2O3 |
 |
Cabozantinib impurity 38 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
 |
Etoposide Impurity 2 |
|
|
 |
Silodosin Carboxylic Acid Impurity |
1431373-77-1 |
C25H31F3N2O5 |
 |
Amlodipine Impurity 27 Disodium Salt |
120289-11-4 |
C19H20ClNO7 |
 |
Caspofungin impurit 2 |
|
|
 |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
 |
Nicergoline Impurity M |
|
|
![3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione](/CAS/GIF/871700-24-2.gif) |
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
C18H15FIN3O4 |
 |
Oxytocin oxide impurity reference substance |
|
|
 |
CyclopropanaMine, 2-(4-fluorophenyl)-(hydrochloride)(1:1),(1R,2S)- |
1314324-00-9 |
C9H11ClFN |
 |
Ticagrelor |
1265919-24-1 |
C12H21NO5 |
 |
Vardenafil Oxopiperazine (IMpurity) |
448184-58-5 |
C21H26N6O5S |
 |
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
 |
EzetiMibe IMpurity 1 |
190595-66-5 |
C24H22FNO3 |
 |
Ticagrelor Impurity 64 |
|
|
 |
Olsalazine Impurity B |
|
|
 |
EzetiMibe IMpurity B |
|
|
 |
Peramivir Intermediate impurity 1 |
|
|
 |
Celecoxib iMpurity-B |
|
|
 |
Empagliflozin Impurity 33 |
|
|
 |
Tofacitinib Impurity 88 |
|
|
 |
Ribavirin Impurity 55 |
119240-35-6 |
C11H16O8 |
 |
Tofacitinib Impurity X |
|
|
 |
Ixazomib Impurity |
|
|
 |
(1R,2S)-2-(3,4-ジフルオロフェニル)シクロプロパンアミン塩酸塩 |
1402222-66-5 |
C9H10ClF2N |
 |
Apremilast |
1384439-80-8 |
C17H16N2O6S |
 |
Cabozantinib Impurity B |
|
|
 |
ACT 373898 |
1433875-14-9 |
C15H17BrN4O5S |
 |
Posaconazole DiastereoisoMer interMediate 2 |
166583-12-6 |
C21H21F2N3O4S |
![N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸](/CAS/GIF/51865-79-3.gif) |
N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸 |
51865-79-3 |
C20H22N8O5 |
 |
1-ベンジル-4-(5,6-ジメトキシ-1-オキソインダン-2-Yリンデンメチル)ピペリジン |
120014-07-5 |
C24H27NO3 |
 |
3-bromo-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl) methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy) benzonitrile |
2994626-87-6 |
C17H11BrF3N5O3 |
 |
Fosaprepitant Impurity 4 |
1523569-85-8 |
C37H34F7N4O6P |
![α,α-Bis[2-(dimethylamino)ethyl]-](/CAS/GIF/1246816-57-8.gif) |
α,α-Bis[2-(dimethylamino)ethyl]- |
1246816-57-8 |
C16H24ClN3 |
 |
vildagliptin Impurity E |
1789703-37-2 |
C17H25N3O2 |
 |
15(R)-17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA |
41639-71-8 |
C23H32O5 |
![1H-Purin-2-amine, 6,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-N-(triphenylmethyl)-](/CAS/20200611/GIF/2097265-84-2.gif) |
1H-Purin-2-amine, 6,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-N-(triphenylmethyl)- |
2097265-84-2 |
C52H49N5O3 |
 |
1,1'-(1,4,8,11-tetraazacyclotetradecane-1,11-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride |
|
C14H24Cl2F6N4O2 |
 |
(1R,3S,4S)-エンテカビル |
1333204-94-6 |
C12H15N5O3 |
 |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
 |
Celecoxib Impurity |
170570-09-9 |
C18H16F3N3O2S |
 |
IverMectin B1 Aglycon |
73162-95-5 |
C34H50O8 |
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
 |
Peramivir Impurity 17 |
|
|
 |
Selegiline Impurity (224Da) |
|
|
 |
Fulvestrant EP Impurity E |
2170200-14-1 |
C32H45F5O3S |
 |
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
![5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one](/CAS/20150408/GIF/452340-96-4.gif) |
5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
C13H15NO4 |
 |
Desmethoxy Fluvoxamine |
1217216-82-4 |
C14H19F3N2O |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
 |
Cefminox sodium impurities Ⅲ |
|
|
 |
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2097505-01-4 |
C34H37N5O5 |
 |
5-Chlorodescyano CitalopraM Oxalate |
64169-46-6 |
C21H23ClFNO5 |
 |
Posaconazole Impurity 51 |
357189-94-7 |
C37H40F2N8O5 |
 |
Vonoprazan Impurity 57 |
|
|
 |
Moxifloxacin Impurity 47 |
|
|
 |
rac a-Hydroxy Ibuprofen |
60057-62-7 |
C13H18O3 |
![rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)](/CAS/20211123/GIF/1882095-50-2.gif) |
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
rac-(R*)-4-アミノ-N,N,N-トリメチル-2-ヒドロキシ-4-オキソブタン-1-アミニウム·クロリド |
5261-99-4 |
C7H18ClN2O2+ |
 |
(R)-Zanubrutinib |
1691249-44-1 |
C27H29N5O3 |
 |
Azilsartan iMpurity G |
|
|
 |
(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate |
169900-32-7 |
C39H70O4Si2 |
 |
Arbidol Impurity I |
153633-10-4 |
C22H24Br2N2O3S |
 |
methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-3- oxopropanoate |
|
|
 |
Oseltamivir Impurity 36 |
|
|
 |
(4-hydroxy-1-(hydroxymethyl)-7-phenoxyisoquinoline-3-carbonyl)glycine |
|
|
 |
2-(DiethylaMino)-N-(2,3-diMethylphenyl)acetaMide Hydrochloride |
857170-72-0 |
C14H23ClN2O |
 |
Aprepitant impurity 2 |
|
|
 |
Rosuvastatin Impurity 111 |
|
|
 |
DiazepaM IMpurity F |
31269-33-7 |
C16H13ClN2O |
 |
S,S-Efinaconazole |
164650-45-7 |
C18H22F2N4O |
 |
Metronidazole Impurity 12 |
|
|
 |
Cefdinir impurity TU mixture |
|
|
![(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/CAS/20180629/GIF/1839099-22-7.gif) |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one |
1839099-22-7 |
C25H26N6O2 |
 |
Afatinib IMpurity A |
|
|
 |
Tirofiban Impurity 19 |
158808-75-4 |
C18H28N2O3 |
![4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-ethoxy-6-[(1-methyl-2-pyrrolidinylidene)amino]-3-quinolinecarbonitrile](/CAS/20200611/GIF/1144516-21-1.gif) |
4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-ethoxy-6-[(1-methyl-2-pyrrolidinylidene)amino]-3-quinolinecarbonitrile |
1144516-21-1 |
C29H27ClN6O2 |
 |
Afatinib Impurity 56 |
|
|
 |
Ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate |
2124269-41-4 |
C16H29N5O4 |